Pharmaceutical Commerce - September/October 2017 - 32

Legal & Regulatory
Clearing the path by understanding the obstacles:
The 2017 Sharing Conference
The Sharing Conference returns to Baltimore in 2017
By Deb Segura, The Sharing Alliance

It's no secret
that compliance
professionals are faced
with an ever-changing
environment of state
and federal regulatory
requirements. Staying
com p l i a n t re qu i re s
more diligence and resourcefulness than
ever before. But having the underlying
knowledge remains paramount; it is
extremely difficult to fully comply with
something that is not properly understood.
Successful compliance requires an in-depth
understanding of both the big-picture goals
of regulators and the practical nuances
of applied best practices. Learning and
knowledge-sharing are the vehicles to that
understanding.
Today's expanded vision of compliance
learning and sharing includes exploration
of important issues such as the safety and
security of our drug supply chain, drug
sample distribution and other marketing
initiatives, transparency requirements,
fraud and abuse, ever-changing state
regulations, and much more. That's why
2017 marks a significant milestone for The
PDMA Alliance: our transition to a new
brand identity.
Brand evolution
In 1990, a small group of pharmaceutical
executives responsible for compliance to
the Prescription Drug Marketing Act of
1987 (PDMA) came together to discuss
the relatively new PDMA and how it was
impacting their work days. They shared
ideas and networked on issues related
to sample accountability. The group
continued to meet annually and grew to
become The PDMA Alliance, a not-forprofit organization. The PDMA Alliance
was founded "by the industry, for the
industry" as the voice of pharmaceutical,
medical device and biotech compliance
professionals.
Over the following 27 years, the Alliance
has expanded its knowledge base well
beyond the Prescription Drug Marketing
Act of 1987, incorporating new content
each year to reflect the challenges facing
our members: OIG guidelines, corporate
integrity agreements, Open Payments,
aggregate spend, investigations, the Drug
Supply Chain Security Act, 340B drug
pricing program and more.
To complement this new knowledge, we
recognized the need to modify our identity.
Over the next few months, you will see our
brand fully evolve from The PDMA Alliance
into The Sharing Alliance. Our rationale
for this is sound: We are well aware that
the issues challenging pharmaceutical,
medical device and biotech compliance

professionals are both broad and deep.
Most certainly, compliance with the PDMA
remains an important industry concern,
and we will continue to share our expertise
in this area with our membership. But as
pharma, biotech and device compliance
needs have changed and multiplied, the
Alliance has expanded in response. We
haven't lost touch with our roots and
still consider ourselves to be the premier
resource on PDMA compliance; instead,
we've expanded to deliver even more to the
compliance community.

Who is The Sharing Alliance?
Our organization is comprised of people
like you: professionals at pharmaceutical,
medical device and biotech companies
who work in compliance, marketing, legal,
sales ops and other job functions who
are motivated to help address the health
concerns of our nation while adhering
to federal and state regulatory mandates.
They attend our annual conference and
become year-round members of our
learning community. Some even volunteer
to serve on our Board and work together to
identify ways the Alliance can better serve

its members.
The Alliance maintains good
relationships w ith the US Food and
Drug Administration (FDA), Centers for
Medicare and Medicaid Services (CMS), the
Office of Inspector General (OIG) and other
agencies to continually understand and
educate the industry on pharmaceutical,
biotech and medical device compliance
business, and security best practices. The
Alliance Board is committed to the ongoing
expansion of the not-for-profit Alliance
by supporting members through dynamic
pharmaceutical industry changes and

2017 SHARING CONFERENCE EXHIBITORS
BEXR LOGISTIX, LLC
Boerne, TX
CCG MARKETING SOLUTIONS
West Caldwell, NJ
DF YOUNG
Berwyn, PA
EPIC FULFILLMENT
Broomfield, CO
G&M HEALTH, LLC
Bridgewater, NJ
GENESIS LOGISTICS
Dayton, NJ

www.bexr.com/logistics

www.corpcomm.com

www.dfyoung.com

www.epicfulfillment.com

www.gmhllc.com

www.genesislogistics.com

PRIORITY SOLUTIONS INTERNATIONAL
Swedesboro, NJ
www.prioritysolutions.com
QPHARMA, INC.
Morristown, NJ

www.qpharmacorp.com

QUINTILESIMS (FORMERLY BUZZEOPDMA)
Richmond, VA
www.quintilesims.com
RGIS, LLC
Auburn Hills, MI
RXS LLC
Manalapan, NJ
SETON HALL LAW
Newark, NJ

www.rgis.com

www.rxsinfo.com

http://law.shu.edu

HOWELL MARKETING SERVICES
Elmira, NY
www.howellmarketingservices.com

STAYINFRONT
Fairfield, NJ

www.stayinfront.com

INTOUCH INSIGHT INC.
Ottawa, ON

SYNERGISTIX
Sunrise, FL

www.synergistix.com

www.intouchinsight.com

IRON MOUNTAIN FULFILLMENT SERVICES
Milpitas, CA
www.ironmountain.com

TEMPTIME CORPORATION
Morris Plains, NJ

J. KNIPPER AND COMPANY, INC.
Lakewood, NJ

VEEVA SYSTEMS
Pleasanton, CA

MEDPRO SYSTEMS
Mt. Arlington, NJ

32 Visit our website at www.PharmaceuticalCommerce.com September | October 2017

www.knipper.com

www.medprosystems.com

WAREHOUSE ANYWHERE
Buffalo, NY

www.temptimecorp.com

www.veevasystems.com

www.warehouseanywhere.com


http://www.bexr.com/logistics http://www.prioritysolutions.com http://www.qpharmacorp.com http://www.corpcomm.com http://www.dfyoung.com http://www.quintilesims.com http://www.epicfulfillment.com http://www.rgis.com http://www.gmhllc.com http://www.rxsinfo.com http://www.genesislogistics.com http://law.shu.edu http://www.howellmarketingservices.com http://www.stayinfront.com http://www.intouchinsight.com http://www.synergistix.com http://www.ironmountain.com http://www.temptimecorp.com http://www.knipper.com http://www.veevasystems.com http://www.medprosystems.com http://www.warehouseanywhere.com http://www.PharmaceuticalCommerce.com

Table of Contents for the Digital Edition of Pharmaceutical Commerce - September/October 2017

Table of Contents
Pharmaceutical Commerce - September/October 2017 - Cover1
Pharmaceutical Commerce - September/October 2017 - Cover2
Pharmaceutical Commerce - September/October 2017 - Table of Contents
Pharmaceutical Commerce - September/October 2017 - 4
Pharmaceutical Commerce - September/October 2017 - 5
Pharmaceutical Commerce - September/October 2017 - 6
Pharmaceutical Commerce - September/October 2017 - 7
Pharmaceutical Commerce - September/October 2017 - 8
Pharmaceutical Commerce - September/October 2017 - 9
Pharmaceutical Commerce - September/October 2017 - 10
Pharmaceutical Commerce - September/October 2017 - 11
Pharmaceutical Commerce - September/October 2017 - 12
Pharmaceutical Commerce - September/October 2017 - 13
Pharmaceutical Commerce - September/October 2017 - 14
Pharmaceutical Commerce - September/October 2017 - 15
Pharmaceutical Commerce - September/October 2017 - 16
Pharmaceutical Commerce - September/October 2017 - 17
Pharmaceutical Commerce - September/October 2017 - 18
Pharmaceutical Commerce - September/October 2017 - 19
Pharmaceutical Commerce - September/October 2017 - 20
Pharmaceutical Commerce - September/October 2017 - 21
Pharmaceutical Commerce - September/October 2017 - 22
Pharmaceutical Commerce - September/October 2017 - 23
Pharmaceutical Commerce - September/October 2017 - 24
Pharmaceutical Commerce - September/October 2017 - 25
Pharmaceutical Commerce - September/October 2017 - 26
Pharmaceutical Commerce - September/October 2017 - 27
Pharmaceutical Commerce - September/October 2017 - 28
Pharmaceutical Commerce - September/October 2017 - 29
Pharmaceutical Commerce - September/October 2017 - 30
Pharmaceutical Commerce - September/October 2017 - 31
Pharmaceutical Commerce - September/October 2017 - 32
Pharmaceutical Commerce - September/October 2017 - 33
Pharmaceutical Commerce - September/October 2017 - 34
Pharmaceutical Commerce - September/October 2017 - Cover3
Pharmaceutical Commerce - September/October 2017 - Cover4
https://www.nxtbook.com/nxtbooks/pharmcomm/202006
https://www.nxtbook.com/nxtbooks/pharmcomm/202003
https://www.nxtbook.com/nxtbooks/pharmcomm/201911
https://www.nxtbook.com/nxtbooks/pharmcomm/201909
https://www.nxtbook.com/nxtbooks/pharmcomm/201906
https://www.nxtbook.com/nxtbooks/pharmcomm/201903
https://www.nxtbook.com/nxtbooks/pharmcomm/201811
https://www.nxtbook.com/nxtbooks/pharmcomm/201809
https://www.nxtbook.com/nxtbooks/pharmcomm/201806
https://www.nxtbook.com/nxtbooks/pharmcomm/20180304
https://www.nxtbook.com/nxtbooks/pharmcomm/20171112
https://www.nxtbook.com/nxtbooks/pharmcomm/20170910
https://www.nxtbook.com/nxtbooks/pharmcomm/20170708
https://www.nxtbook.com/nxtbooks/pharmcomm/20170506
https://www.nxtbook.com/nxtbooks/pharmcomm/20170304
https://www.nxtbook.com/nxtbooks/pharmcomm/20170102
https://www.nxtbook.com/nxtbooks/pharmcomm/20161112
https://www.nxtbook.com/nxtbooks/pharmcomm/20160910
https://www.nxtbook.com/nxtbooks/pharmcomm/20160708
https://www.nxtbook.com/nxtbooks/pharmcomm/20160506
https://www.nxtbook.com/nxtbooks/pharmcomm/20160304
https://www.nxtbook.com/nxtbooks/pharmcomm/20160102
https://www.nxtbook.com/nxtbooks/pharmcomm/20151112
https://www.nxtbook.com/nxtbooks/pharmcomm/20150910
https://www.nxtbook.com/nxtbooks/pharmcomm/20150708
https://www.nxtbook.com/nxtbooks/pharmcomm/20150506
https://www.nxtbook.com/nxtbooks/pharmcomm/20150304
https://www.nxtbook.com/nxtbooks/pharmcomm/20150102
https://www.nxtbook.com/nxtbooks/pharmcomm/20141112
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchaindirectory2014
https://www.nxtbook.com/nxtbooks/pharmcomm/20140910
https://www.nxtbook.com/nxtbooks/pharmcomm/20140708
https://www.nxtbook.com/nxtbooks/pharmcomm/20140506
https://www.nxtbook.com/nxtbooks/pharmcomm/20140304
https://www.nxtbook.com/nxtbooks/pharmcomm/20140102
https://www.nxtbook.com/nxtbooks/pharmcomm/dataservicedirectory
https://www.nxtbook.com/nxtbooks/pharmcomm/20131112
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910_hubreport
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910
https://www.nxtbook.com/nxtbooks/pharmcomm/20130708
https://www.nxtbook.com/nxtbooks/pharmcomm/20130506
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchain2013
https://www.nxtbook.com/nxtbooks/pharmcomm/20130304
https://www.nxtbook.com/nxtbooks/pharmcomm/20130102
https://www.nxtbook.com/nxtbooks/pharmcomm/20121112
https://www.nxtbook.com/nxtbooks/pharmcomm/20120910
https://www.nxtbook.com/nxtbooks/pharmcomm/20120708
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506_coldchain
https://www.nxtbook.com/nxtbooks/pharmcomm/20120304
https://www.nxtbook.com/nxtbooks/pharmcomm/20120102
https://www.nxtbook.com/nxtbooks/pharmcomm/20111112
https://www.nxtbook.com/nxtbooks/pharmcomm/20110910
https://www.nxtbook.com/nxtbooks/pharmcomm/20110708
https://www.nxtbook.com/nxtbooks/pharmcomm/20110506
https://www.nxtbook.com/nxtbooks/pharmcomm/20110304
https://www.nxtbook.com/nxtbooks/pharmcomm/20110102
https://www.nxtbook.com/nxtbooks/pharmcomm/20101112
https://www.nxtbook.com/nxtbooks/pharmcomm/20100910
https://www.nxtbook.com/nxtbooks/pharmcomm/20100708
https://www.nxtbook.com/nxtbooks/pharmcomm/20100506
https://www.nxtbook.com/nxtbooks/pharmcomm/201004
https://www.nxtbook.com/nxtbooks/pharmcomm/201003
https://www.nxtbook.com/nxtbooks/pharmcomm/20100102
https://www.nxtbook.com/nxtbooks/pharmcomm/20091112
https://www.nxtbookmedia.com